Vontobel Holding »

4d Molecular Therapeutics In shares owned by Vontobel Holding

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Vontobel Holding from 13F filings

Historical chart of Vontobel Holding investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Vontobel Holding consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Vontobel Holding

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.9M 143k 20.26
2023-03-31 $1.4M 81k 17.19
2022-12-31 $1.2M 54k 22.21

More positions owned by Vontobel Holding

Microsoft Corporation (MSFT)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Alcon Ord Shs (ALC)
Ubs Group SHS (UBS)
Logitech Intl S A SHS (LOGI)
Apple (AAPL)
Applied Materials (AMAT)
NVIDIA Corporation (NVDA)
MercadoLibre (MELI)
Synopsys (SNPS)
Trip Com Group Ads (TCOM)
Linde SHS (LIN)
Mastercard Incorporated Cl A (MA)
Pdd Holdings Sponsored Ads (PDD)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Vontobel Holding

Top funds holding 4d Molecular Therapeutics In

Viking Global Investors
RA Capital Management
BVF
VR Adviser
Henderson Group
Vanguard Group
Arrowpoint Asset Management
Casdin Capital
Goldman Sachs Group
Dimensional Fund Advisors
Deutsche Bank Aktiengesellschaft
Eagle Health Investments
Assenagon Asset Management
Jpmorgan Chase & Co
Point72 Asset Management

View all funds holding 4d Molecular Therapeutics In